Is a complete CLDI research report available?

No complete published report is available for Calidi Biotherapeutics, Inc. (CLDI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Calidi Biotherapeutics, Inc. (CLDI)

NYSEAMERICAN: CLDI · USD

$0.10

-0.00 (-4.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CLDI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.9M
Net income (ttm)	-25M
EPS (ttm)	-$3.96
Shares out	19.5M
Volume	40,137,490
Beta	1.31

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -25M
EPS (ttm): -$3.96
Market cap: 1.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CLDI indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

USD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001855485
Company name	Calidi Biotherapeutics, Inc.
Country	United States
Country code	US
Cusip	320703408
Employees	29
Employees Change	1%
Employees Change Percent	3.57
Enterprise value	$-2.4M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US3207034089
Last refreshed	2026-07-25
Market cap	$1.9M
Market cap category	Nano-Cap
Price	$0.1
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2836
Symbol	CLDI
Website	https://www.calidibio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1,285.09%
FCF yield	-945.24%
P/B ratio	0.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-25M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Profit Per Employee	$-862,414
ROA	-98.18
Roa5y	-244.3
ROCE	-336.5
ROE	-312.4
ROIC	-126.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-98.88%
Cagr3y	-95.7%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$9.6M
Cash	$6.6M
Current Assets	$7.4M
Current Liabilities	$3.8M
Debt	$2.3M
Debt Equity	$0.46
Equity	$4.9M
Interest Coverage	-70.93
Liabilities	$4.7M
Long Term Assets	$2.2M
Long Term Liabilities	$820,000
Net Cash	$4.4M
Net Cash By Market Cap	$225
Net Cash Growth	-25.31%
Net Debt Equity	$-0.89
Tangible Book Value	$4.9M
Tangible Book Value Per Share	$0.41
WACC	10.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.92
Net Working Capital	$-1.6M
Quick ratio	1.73
Working Capital	$3.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-445.7%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-98.87%
200-day SMA	0.74
3Y total return	-99.99%
50-day SMA	0.16
50-day SMA vs 200-day SMA	50under200
All Time High	1,654.9
All Time High Change	-99.99%
All Time High Date	2023-08-28
All Time Low	0.1
All Time Low Change	5.26%
All Time Low Date	2026-07-22
ATR	0.01
Beta	1.31
Beta1y	2.6
Beta2y	0.87
Ch YTD	-91.45
High	0.11
High52	10.92
High52 Date	2025-07-29
High52ch	-99.08%
Low	0.1
Low52	0.1
Low52 Date	2026-07-22
Low52ch	5.26%
Ma50ch	-36.43%
Premarket Change Percent	1.52
Premarket Price	$0.11
Premarket Volume	32,747,527
Price vs 200-day SMA	-86.52%
RSI	28.86
RSI Monthly	8.08
RSI Weekly	26.06
Sharpe ratio	-3.43x
Sortino ratio	-3.68
Total Return	-445.7%
Tr YTD	-91.45
Tr1m	-35.9%
Tr1w	-15.9%
Tr3m	-54.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-19.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,001,786%
Float Percent	97.64%
Net Borrowing	-867,000
Shares Insiders	1.59%
Shares Institutions	10.64%
Shares Out	19,461,625
Shares Qo Q	44.73%
Shares Yo Y	445.7%
Short Float	22.5%
Short Ratio	0.77
Short Shares	21.97

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-20.1M
Average Volume	7,752,251.4x
Bv Per Share	0.41
CAPEX	$-118,000
Ch1m	-35.9
Ch1w	-15.9
Ch1y	-98.87
Ch3m	-54.55
Ch3y	-99.99
Ch6m	-90.2
Change	-4.76%
Change From Open	-5.21
Close	0.11
Days Gap	0.48
Depreciation Amortization	1,683,000
Dollar Volume	4,013,749
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-19.4M
EBITDA	$-17.7M
EPS	$-3.96
F Score	1
FCF	$-18.4M
FCF EV Yield	757.71x
FCF Per Share	$-0.95
Financing CF	14,510,000
Fiscal Year End	December
Founded	2,014
Income Tax	$16,000
Investing CF	-168,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2025-08-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-27
Ma150	0.49
Ma150ch	-79.5%
Ma20	0.13
Ma20ch	-24.98%
Net CF	-3,929,000
Next Earnings Date	2026-08-07
Open	0.11
Optionable	No
Position In Range	30.57
Ppne	2,100,000
Pre Close	0.11
Price Date	2026-07-24
Ptbv Ratio	0.39
Relative Volume	5.18x
Share Based Comp	1,732,000
Tr6m	-90.2%
Us State	California
Volume	40,137,490

Calidi Biotherapeutics, Inc. (CLDI)

Coverage state: Market snapshot only — no published research

Generate the first CLDI analysis

Price

Financial snapshot

Fair-value bridge

Latest news · CLDI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLDI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CLDI

Frequently asked questions